CXCL10 expression and prognostic significance in stage II and III colorectal cancer
- 10 October 2009
- journal article
- Published by Springer Science and Business Media LLC in Molecular Biology Reports
- Vol. 37 (6), 3029-3036
- https://doi.org/10.1007/s11033-009-9873-z
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapyInternational Journal of Cancer, 2008
- Adjuvante Therapie des KolonkarzinomsOnkologie, 2008
- Expression of IP-10 related to angiogenesis in uterine cervical cancersBritish Journal of Cancer, 2007
- Expression of CXCR3 on Mononuclear Cells and CXCR3 Ligands in Patients With Metastatic Renal Cell Carcinoma in Response to Systemic IL-2 TherapyJournal of Immunotherapy, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid TumorsClinical Cancer Research, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Inflammation and cancerNature, 2002
- Combination of Interleukin 12 and Interferon α Gene Therapy Induces a Synergistic Antitumor Response against Colon and Renal Cell CarcinomaHuman Gene Therapy, 2000
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971